May 23, 2025 04:11PM Movano (MOVE) receives Nasdaq notice on late 10-Q

May 16, 2025 04:33PM Movano (MOVE) to explore strategic alternatives

Jan 2, 2025 08:03AM Movano (MOVE) Appoints Shaheen Wirk to its Board

Dec 2, 2024 09:23AM Movano (MOVE) Receives FDA Clearance for EvieMED Ring

Nov 14, 2024 05:39PM Movano (MOVE) Misses Q3 EPS by 100c

Nov 4, 2024 08:02AM Movano (MOVE) Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split

Nov 4, 2024 08:02AM Movano (MOVE) Submits Response to FDA as Part of Final Review Phase for EvieMED

Oct 31, 2024 08:31AM Movano (MOVE) Opens Investigation to Expose Apparent Stock Manipulation

Oct 25, 2024 09:00AM Movano (MOVE) Announces Reverse Stock Split

Oct 24, 2024 08:00AM Movano (MOVE) Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Oct 10, 2024 08:01AM Movano (MOVE) Provides Update on FDA Review of EvieMED Ring

Sep 3, 2024 08:01AM Movano (MOVE) Advances to Final Phase of FDA Review Process for EvieMED Ring

Aug 14, 2024 04:08PM Movano (MOVE) Reports Q2 Loss of $0.06

Aug 5, 2024 09:01AM Movano (MOVE) Provides Progress Update on EvieMED Regulatory Filing

Jun 13, 2024 09:02AM Movano (MOVE) Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion